Standard-of-Care, Second-Line, and Future Therapies for GEJ and Esophageal Adenocarcinoma

2025-02-20

Above Video forward from Youtube Medscape, copyright belongs to the original author, please contact us if any problem! Medscape

Post comments

click

Comment Record：

Recommended videos

Who Benefits from Adjuvant Immunotherapy in Melanoma? Insights From Biomarker Data

Jail Not the Answer to Deal With Mentally Ill People, Says Ethicist

GETTING MY WISDOM TEETH REMOVED!!

EATING WORLD'S SPICIEST VS SOUREST FOODS!!

I Built 3 SECRET Rooms in ONE COLOR!

I Exposed The WORST Rated Airlines!

Scroll to Top